A laboratory scientist in a white coat and gloves examines a petri dish with a pipette at a lab workstation, surrounded by laboratory glassware and scientific equipment.
| |

Glycolysis: Steps, Products & Enzyme Deficiencies

Glycolysis shows up on Step 1 more than students expect. It is not just a list of ten enzymes to memorize and forget. The exam uses it as an anchor for regulation, enzyme deficiency recognition, and clinical reasoning about energy metabolism. Every year, questions about lactic acidosis, hemolytic anemia, and cancer metabolism trace back to concepts that live entirely inside this pathway.

What follows is the glycolysis information that actually moves scores: the glycolysis steps that are tested by name, the net-yield math, the PFK-1 regulatory axis, and the enzyme deficiencies the test reaches for repeatedly. Students who are performing well can use this to build a working map they can reason from. Students who are struggling can use it to stabilize the highest-yield pieces first, then fill in the rest.

What Glycolysis Does (and Where It Does It)

Glycolysis — Overview

Glycolysis converts one molecule of glucose into two molecules of pyruvate. Every step occurs in the cytosol. No mitochondria are required, which is exactly why red blood cells (which lack mitochondria entirely) depend on it as their sole ATP source.

The pathway splits into two phases. Steps 1 through 5 make up the investment phase: the cell spends 2 ATP to phosphorylate and cleave glucose. Steps 6 through 10 make up the payoff phase: the cell generates 4 ATP and 2 NADH from two molecules of glyceraldehyde-3-phosphate. The net result is 2 ATP, 2 NADH, and 2 pyruvate per glucose.

That number, 2 ATP net, is what Step 1 means when it asks about the ATP yield of glycolysis. Not 36, not 38, not 32. Those larger numbers include oxidative phosphorylation. Glycolysis alone yields 2.

All 10 Glycolysis Steps
All 10 Glycolysis Steps at a Glance
Investment phase Payoff phase Irreversible / regulatory
Investment · Steps 1–5 · Consumes 2 ATP
1
Hexokinase / Glucokinase Irreversible
Glucose → Glucose-6-P −1 ATP
2
Phosphoglucose Isomerase
Glucose-6-P → Fructose-6-P
3
PFK-1 Rate-Limiting
Fructose-6-P → Fructose-1,6-bisP −1 ATP
4
Aldolase A
Fructose-1,6-bisP → G3P + DHAP
5
Triose Phosphate Isomerase
DHAP → G3P · Everything ×2 from here
Payoff · Steps 6–10 · Generates 4 ATP, 2 NADH
6
GAPDH
G3P → 1,3-bisphosphoglycerate +2 NADH
7
Phosphoglycerate Kinase
1,3-bisP → 3-phosphoglycerate +2 ATP
8
Phosphoglycerate Mutase
3-phosphoglycerate → 2-phosphoglycerate
9
Enolase
2-phosphoglycerate → PEP + H₂O
10
Pyruvate Kinase Irreversible
PEP → Pyruvate +2 ATP

Net Yield: The Numbers Step 1 Asks About

Students spend too much time trying to memorize whether the total aerobic yield is 30, 32, 36, or 38 ATP. The glycolysis products that actually appear on Step 1 questions are the net figures: 2 ATP, 2 NADH, and 2 pyruvate per glucose. The total aerobic yield varies by source and by which NADH shuttle assumption you use. What does not vary, and what appears on board questions without ambiguity, is the net yield of glycolysis itself.

Glycolysis Net Yield
2
ATP (net)
Produced at steps 7 & 10 (substrate-level phosphorylation); 2 invested at steps 1 & 3
2
NADH (net)
Generated at step 6 (GAPDH). Carries electrons to mitochondria under aerobic conditions
2
Pyruvate (net)
Final product (step 10). Fate diverges based on oxygen availability

⚠ Common Mistake

Confusing the net ATP yield of glycolysis (2) with the total aerobic yield of glucose oxidation (~30–32). If a question specifies “glycolysis only” or asks about an anaerobic cell, the answer is 2 ATP. Picking a larger number here is a reliable indicator that the concept has not yet been sorted out.

The Three Irreversible Enzymes

The Three Irreversible Enzymes

These three enzymes catalyze reactions that are thermodynamically irreversible under physiologic conditions. They are the primary regulatory points of glycolysis, and they are the exact steps gluconeogenesis must bypass with different enzymes. If only one thing gets memorized from this section, it should be this table.

Enzyme Step Tissue Key Regulation Gluconeogenesis Bypass
Hexokinase / Glucokinase Step 1 Hexokinase: most tissues. Glucokinase: liver and β-cells only. Hexokinase inhibited by G6P. Glucokinase: high Km, not product-inhibited, induced by insulin. Glucose-6-phosphatase
Phosphofructokinase-1 (PFK-1) Step 3 All tissues Rate-limiting. Activated by AMP, F-2,6-BP. Inhibited by ATP, citrate. Fructose-1,6-bisphosphatase
Pyruvate Kinase Step 10 All tissues (PKLR isoform in RBCs and liver) Activated by F-1,6-BP (feed-forward). Inhibited by ATP, alanine. Glucagon suppresses via phosphorylation. Pyruvate carboxylase + PEPCK
Glycolysis Mnemonic
◆ Glycolysis Mnemonic — Intermediates in Order
Goodness Gracious, Father Franklin Did Go By Picking Pumpkins Prepared
GGlucose
GGlucose-6-phosphate
FFructose-6-phosphate
FFructose-1,6-bisphosphate
DDHAP
GGlyceraldehyde-3-phosphate
B1,3-bisphosphoglycerate
P3-phosphoglycerate
P2-phosphoglycerate
PPEP → Pyruvate

PFK-1: The Glycolysis Rate-Limiting Enzyme

PFK-1 is the glycolysis rate-limiting enzyme, the committed step that determines whether a cell is running glycolysis at full speed or holding back. Committed means that once fructose-6-phosphate is converted to fructose-1,6-bisphosphate, the cell is committed to completing the pathway. Regulation here reflects the cell’s energy state.

The logic is worth internalizing rather than memorizing in isolation. When AMP is high, the cell is depleted of energy, and PFK-1 accelerates. When ATP and citrate are high, the cell has plenty of fuel, and PFK-1 slows. Fructose-2,6-bisphosphate (F-2,6-BP), produced by the bifunctional enzyme PFK-2/FBPase-2, is the most potent activator of PFK-1 and the central target of insulin and glucagon signaling.

PFK-1 Allosteric Regulation
PFK-1 Allosteric Regulation
PFK-1
Step 3 · Rate-Limiting · Committed Step
Activators — Glycolysis On
AMP — Low energy signal. Allosteric activation; tells the cell it needs more ATP urgently.
Fructose-2,6-bisphosphate — Most potent activator. Produced by PFK-2 when insulin signals the fed state.
Inhibitors — Glycolysis Off
ATP — Energy-replete signal. Allosteric inhibition at a separate regulatory site.
Citrate — TCA cycle intermediate. Signals that downstream fuel is already adequate.
Insulin vs. Glucagon: The PFK-2 Axis
Insulin (Fed State)
1Insulin activates protein phosphatase
2Dephosphorylation activates PFK-2 kinase activity
3F-2,6-BP rises → PFK-1 fully activated
4Result: glycolysis accelerates in the liver
Glucagon (Fasted State)
1Glucagon raises cAMP → activates PKA
2PKA phosphorylates bifunctional enzyme → activates FBPase-2
3F-2,6-BP falls → PFK-1 inhibited
4Result: gluconeogenesis favored in the liver
Hexokinase vs. Glucokinase

Hexokinase has a low Km (high affinity for glucose) and is inhibited by its product, glucose-6-phosphate; it operates near saturation at normal blood glucose levels. Glucokinase has a high Km (low affinity) and is not product-inhibited. This makes glucokinase a glucose sensor: activity increases proportionally as postprandial glucose rises, allowing the liver to buffer the glucose load. Glucokinase mutations cause MODY type 2.

Aerobic vs. Anaerobic Glycolysis

Glycolysis itself is the same ten steps regardless of oxygen availability. The divergence occurs after pyruvate is produced at step 10. When oxygen is available, pyruvate is converted to acetyl-CoA and enters the Krebs cycle.

Aerobic vs Anaerobic Glycolysis
🫁 Aerobic Glycolysis
→
Pyruvate enters mitochondria via pyruvate dehydrogenase complex (PDH), converted to acetyl-CoA
→
Acetyl-CoA enters TCA cycle, yielding NADH and FADH₂ for oxidative phosphorylation
→
Total ATP yield: ~30–32 per glucose (shuttle-dependent)
→
CO₂ produced; NADH shuttled into mitochondria
💪 Anaerobic Glycolysis
→
Pyruvate → lactate via lactate dehydrogenase (LDH)
→
Key purpose: regenerates cytosolic NAD+ so GAPDH (step 6) can keep running
→
ATP yield: 2 per glucose only
→
No CO₂; lactate exported to liver (Cori cycle) for recycling to glucose

Two Concepts Worth Knowing Cold

The Pasteur Effect: Oxygen suppresses the rate of glycolysis. Aerobic conditions raise ATP and citrate, which inhibit PFK-1. Glucose consumption slows because the cell no longer needs to burn it at high speed to maintain ATP. Hypoxia accelerates glycolysis by the same logic in reverse.

The Warburg Effect: Cancer cells preferentially perform aerobic glycolysis, producing lactate even when oxygen is present. This is the basis of ¹⁸F-FDG PET imaging. Tumors consume glucose at high rates and appear as bright spots on PET. Step 1 questions about cancer metabolism or PET scans connect back here.

Glycolysis-Dependent Tissues

High-Yield: Glycolysis-Dependent Tissues

Mature RBCs (no mitochondria), cornea, lens, renal medulla, and testes rely heavily or exclusively on anaerobic glycolysis for ATP. RBCs are the highest-yield of these. The reason pyruvate kinase deficiency causes hemolytic anemia (and not a myopathy) is that RBCs have no backup pathway.

Enzyme Deficiencies Step 1 Tests

Three deficiencies come up repeatedly. Each has a distinct clinical signature. The trap with Von Gierke is that it looks like a glycolysis defect but is actually a block in gluconeogenesis and glycogenolysis. The trap with pyruvate kinase deficiency is that students expect spherocytes and do not find them.

Glycolytic Enzyme Deficiencies
Pyruvate Kinase Deficiency
Most Common Glycolytic Enzymopathy
Gene
PKLR (Chr 1q21); autosomal recessive
Mechanism
RBCs cannot complete glycolysis → ATP depletion → loss of membrane deformability → extravascular hemolysis
Smear
Echinocytes (“burr cells”). No spherocytes. 2,3-BPG rises → right-shift O₂-Hb curve.
Treatment
Mitapivat (PK activator, FDA-approved 2022). Transfusions for severe cases.
⚠ Trap: Expect echinocytes, not spherocytes. Absence of spherocytes rules out hereditary spherocytosis.
Glucokinase Deficiency (MODY 2)
Hexokinase IV — β-Cell Glucose Sensor
Gene
GCK; autosomal dominant. One of the most common MODY subtypes.
Mechanism
β-cells cannot sense glucose normally → glucose threshold for insulin secretion rises → mild fasting hyperglycemia
Presentation
Mild, stable hyperglycemia (typically 100–145 mg/dL). Often found incidentally or during pregnancy.
Treatment
Usually none required. Diet modification. Insulin during pregnancy if needed.
⚠ Trap: Mild fasting hyperglycemia in a young patient with family history that never progresses = MODY 2, not Type 2 diabetes.
Von Gierke Disease (GSD Type Ia)
Glucose-6-Phosphatase Deficiency: Not a Glycolysis Enzyme
Gene
G6PC; autosomal recessive. Incidence ~1:100,000.
Mechanism
Cannot release free glucose from G6P → gluconeogenesis and glycogenolysis both fail → fasting hypoglycemia. G6P is diverted into glycolysis, producing excess lactate.
Presentation
Fasting hypoglycemia, hepatomegaly, lactic acidosis, hyperuricemia, hyperlipidemia. Presents ~3–6 months of age.
Classic Trap
Lactic acidosis here comes from excess glycolysis, not from hypoxia. Recognize the metabolic pattern.
⚠ Trap: The lactic acidosis is a glycolysis overflow, not a hypoxic event. The defect is in gluconeogenesis, not glycolysis itself.
PFK Deficiency (Tarui / GSD VII)
Muscle PFK, PFKM Gene
Gene
PFKM; autosomal recessive. Very rare (<100 cases reported).
Mechanism
Muscle PFK deficiency → glycolysis blocked at step 3 in muscle and partially in RBCs
Presentation
Exercise intolerance, cramps, myoglobinuria. Hemolytic anemia (mild). Symptoms do not improve with carbohydrate loading, which distinguishes Tarui from McArdle (GSD V).
Classic Trap
Carbohydrate meal worsens symptoms in Tarui. In McArdle, the “second wind” is the distinguishing clinical feature.
⚠ Trap: Carbs worsen Tarui (substrate floods a blocked step). Carbs help in McArdle. Get that distinction cold.

How to Study This Based on Where You Are

Performing Well vs Struggling
If You’re Performing Well
  • Master the PFK-2/FBPase-2 bifunctional enzyme axis. Know the insulin vs. glucagon effect at the molecular level: which PKA phosphorylation event activates, and what happens to F-2,6-BP.
  • Connect glycolysis to the TCA cycle via PDH and to gluconeogenesis via the bypass enzymes. Questions that test both pathways in one vignette require that map.
  • Know why 2,3-BPG rises in PK deficiency, why that right-shifts the O₂-Hb curve, and why the anemia is better tolerated than the hemoglobin level suggests.
  • Practice Warburg-effect and lactic acidosis questions. The clinical application is where high-scorers separate.
If You’re Struggling to Keep Up
  • Anchor to the three irreversible enzymes and their clinical consequences first. Steps 2, 4, 5, 8, and 9 are almost never the answer on Step 1.
  • Memorize the net yield cold: 2 ATP, 2 NADH, 2 pyruvate. No exceptions for the glycolysis number.
  • Learn one discriminating fact per deficiency: echinocytes/no spherocytes for PK deficiency; high Km/MODY for glucokinase; lactic acidosis plus fasting hypoglycemia for Von Gierke.
  • Do not memorize all 10 steps in detail before owning the regulation and deficiency material. The payoff phase is secondary to the regulatory logic.

What Wastes Time on This Topic

Common Time Wasters

Common Time Wasters

Drawing the full pathway repeatedly without testing yourself on it. Memorizing the exact ATP counts for aerobic respiration across all sources (the numbers genuinely vary by textbook; know “~30–32” and move on). Over-reading enzyme kinetics for steps 2, 4, 5, 8, and 9, none of which are regulatory or have associated deficiency syndromes. Getting lost in the Warburg effect mechanistic literature instead of knowing the exam point: cancer cells preferentially use glycolysis even with O₂, which is the basis of PET imaging.

Practice Questions

Work through these before reviewing the explanations. The stem logic reflects how Step 1 actually constructs glycolysis questions.

Glycolysis Clinical Vignettes
1Hematology · Enzyme Deficiency

A 4-month-old male is brought for evaluation of jaundice and pallor. Labs show hemoglobin 7.8 g/dL, elevated indirect bilirubin, and elevated LDH. Peripheral smear shows irregularly spiculated red cells with no spherocytes. Osmotic fragility testing is normal. Upstream glycolytic intermediates are elevated. Which enzyme deficiency is most consistent with this presentation?

Answer & Explanation

Pyruvate kinase deficiency. The key discriminators are: (1) echinocytes (burr cells), not spherocytes, which suggest hereditary spherocytosis or immune hemolysis; (2) normal osmotic fragility, ruling out hereditary spherocytosis; (3) elevated upstream intermediates, because the block is at pyruvate kinase (step 10), so everything upstream accumulates, including 2,3-BPG, which rises to compensate by right-shifting the O₂-Hb curve. The autosomal recessive PKLR mutation causes the PKLR isoform to malfunction specifically in RBCs and liver.

2Metabolism · Von Gierke

A 6-month-old presents with severe fasting hypoglycemia, hepatomegaly, and elevated serum lactate. Glucose-6-phosphatase activity is absent on liver biopsy. Which of the following best explains the lactic acidosis in this patient?

Answer & Explanation

Excess glycolysis from accumulated glucose-6-phosphate. Without glucose-6-phosphatase, G6P cannot be converted to free glucose and exits via glycolysis instead, producing excess pyruvate and lactate. This is not Type A lactic acidosis from hypoxia; it is a metabolic consequence of pathway redirection. The high-yield lesson: lactic acidosis in Von Gierke is a glycolysis overflow, not an oxygen-delivery problem. Recognize the constellation: fasting hypoglycemia, lactic acidosis, hepatomegaly, and hyperuricemia.

3Endocrinology · MODY

A 28-year-old woman is found to have fasting glucose of 118 mg/dL on a routine screening panel. She has no symptoms. Her mother had a similar finding for years without progression to diabetes or complications. Genetic testing reveals a heterozygous GCK mutation. What is the mechanism of her hyperglycemia?

Answer & Explanation

Glucokinase deficiency (MODY type 2). Glucokinase acts as the glucose sensor in pancreatic β-cells. Its high Km means activity is proportional to glucose concentration over the physiologic range. With reduced glucokinase function, the threshold for insulin secretion rises; the β-cell requires a higher blood glucose level before releasing insulin. The result is mild, stable fasting hyperglycemia that rarely progresses. This is not Type 1 or Type 2 diabetes; it is a glucokinase (hexokinase IV) deficiency. Autosomal dominant inheritance means one functional allele is lost.

Ready to Test What You Know?

Free USMLE Step 1 Practice Questions

Ready to Test What You Know?

Reading the pathway is the easy part. Try our free USMLE Step 1 practice questions, written as clinical vignettes in the same format as the real exam, and see which biochemistry concepts actually stick before exam day.

Try Free Questions →